Abstract:
Purpose: In patients with hematological malignancies and central venous catheters (CVC) men have a higher risk for CVC related bloodstream infections (CRBSI) than women. Hence, preventive strategies such as earlier CVC removal may reduce the overall CRBSI (oCRBSI) rate.
Methods: A randomized simulation using data from a CVC registry was performed. Data were derived from unselected patients with hematological or oncological diseases and a CVC. Patients were randomized to an experimental (EXP-G) or control group (CON-G). For the men in the EXP-G, one-day increments of an earlier CVC removal were simulated based on actual data and compared to men in the CON-G without simulation. The primary endpoint was oCRBSI rate.
Results: Underlying diseases were mainly hematological malignancies (87.3%). In the male patients with a median CVC in situ time of 13 days, the oCRBSI rate was 7.3% (103/1408), with 7.3% (53/729) in the EXP-G and 7.4% (50/679) in the CON-G. In the EXP-G, simulated shortening of CVC time by 1 day in men resulted in an oCRBSI rate of 5.2% compared with 7.4% in the CON-G (p = 0.12). Shortening CVC time by 2 days led to an oCRBSI rate of 4% (p = 0.008); the corresponding median CVC time was 11 days. A 3-day shortening further to 10 days reduced the oCRBSI rate to 2.7% (p < 0.001). Women from the same registry showed a 3.3% (30/920) oCRBSI rate after 12 days.
Conclusion: In conclusion, shortening the CVC dwell time in men by 2 or 3 days, corresponding to a CVC duration of 10-11 days, reduces the CRBSI rate in men and mitigates the higher risk, compared to women.
Clinical Trial Registration: SECRECY (Study to Evaluate Central Venous Catheter-related Infections in Hematology and Oncology) was registered within the German Clinical Trial Register (DRKS; no. DRKS00006551) on 29 September 2014.
Reference:Kriege O, Böll B, Brüder N, Giesen N, Lanznaster J, Mertins S, Minti A, Naendrup JH, Schmidt-Hieber M, Seggewiss-Bernhardt R, Weber P, Wille K, Panse J, Hentrich M, Schalk E; SECRECY Investigators. Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study. Infection. 2026 Jul 10. doi: 10.1007/s15010-026-02888-7. Epub ahead of print. PMID: 42430117.